Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 4;16(9):e68639.
doi: 10.7759/cureus.68639. eCollection 2024 Sep.

The Role of Pulmonary Drug Delivery in Modern Therapeutics: An Overview

Affiliations
Review

The Role of Pulmonary Drug Delivery in Modern Therapeutics: An Overview

Prem Kumar Subramani et al. Cureus. .

Abstract

The pulmonary drug delivery system is a promising and evolving technology in which the prescribed medicine is breathed through the lungs, and subsequently, it enters the circulation via the alveolar epithelium. This category of pulmonary drug delivery system is an appealing and non-invasive administration method. Pulmonary drug delivery is most commonly utilized to treat airway problems by providing locally active medicines directly to their site of action. The dose required to have a pharmacological effect is reduced when medicines are delivered directly to their site of action. In addition to locally acting medications, the pulmonary route can be utilized to deliver compounds with systemic effects, such as in the case of insulin inhalation therapy for systemic absorption. Particle size, bioavailability, device compatibility, and other aspects must be addressed, including the formulation of drugs into an acceptable dosage for inhalation with sufficient stability. This formulation must also be used in conjunction with a suitable inhaler device that produces an aerosol with a particle or droplet size that assures deposition in the required targeted area of the pulmonary system. Recent advancements in pulmonary drug delivery include the development of targeted nanoparticles and inhalable biologics, which enhance drug absorption and efficacy while minimizing systemic side effects. Future directions focus on personalized medicine approaches and advanced inhalation technologies, although limitations such as variable patient adherence and the need for precise dosing continue to pose challenges.

Keywords: approaches in pulmonary drug delivery; devices for pulmonary disease conditions; drug deposition; formulation of drugs; lung infection.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Mechanism of drug deposition.
The respective image is the original work of the author representing the mechanism of drug deposition [2,3].
Figure 2
Figure 2. Schematic representation mechanism of drug deposition
The respective image is the original work of the author representing the schematic mechanism of drug deposition [2,3].

References

    1. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Mangal S, Gao W, Li T, Zhou QT. Acta Pharmacol Sin. 2017;38:782–797. - PMC - PubMed
    1. Next generation mucosal vaccine strategy for respiratory pathogens. Dotiwala F, Upadhyay AK. Vaccines (Basel) 2023;11 - PMC - PubMed
    1. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. Byron PR, Hindle M, Lange CF, et al. J Aerosol Med Pulm Drug Deliv. 2010;23 Suppl 2:0–69. - PubMed
    1. Recent advances in testing of microsphere drug delivery systems. Andhariya JV, Burgess DJ. Expert Opin Drug Deliv. 2016;13:593–608. - PubMed
    1. Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review. Xu Y, Liu H, Song L. J Nanobiotechnology. 2020;18:145. - PMC - PubMed

LinkOut - more resources